AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call Transcript April 2, 2025AngioDynamics, Inc. beats earnings expectations.
Posts Tagged ‘NASDAQ:ANGO’
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript January 8, 2025AngioDynamics, Inc. beats earnings expectations.
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript October 3, 2024AngioDynamics, Inc. beats earnings expectations.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2024 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2024 Earnings Call Transcript July 16, 2024AngioDynamics, Inc. misses on earnings expectations.
5 Micro-Cap Healthcare Stocks Insiders Are Buying
This article presents an overview of 5 Micro-Cap Healthcare Stocks Insiders Are Buying. For a detailed overview of such stocks read our article, 10 Micro-Cap Healthcare Stocks...
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript
AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.09.
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2024 First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Second Quarter Earnings Call. At this time all participants are in listen-only-mode.
Where Do Hedge Funds Stand On AngioDynamics, Inc. (ANGO)?
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
Should I Buy AngioDynamics, Inc. (ANGO)?
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Is ANGO A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Hedge Funds Never Been Less Bullish On AngioDynamics, Inc. (ANGO)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Do Hedge Funds Love AngioDynamics, Inc. (ANGO)?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is AngioDynamics, Inc. (ANGO) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is AngioDynamics, Inc. (ANGO) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Here’s What Hedge Funds Think About AngioDynamics, Inc. (ANGO)
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
13D Filing: Avista Capital Partners Gp, Llc and Angiodynamics Inc (NASDAQ:ANGO)
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d...
Should You Follow the Smart Money Surge into AngioDynamics, Inc. (ANGO)?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capital’s Investment Moves?
At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on.
Juno Therapeutics, Kite Pharma, & Petrobras Among the Morning’s Trending Stocks
Crude futures are 1% lower today after yesterday's disappointing API inventory data.
Small-Cap Healthcare Stocks That Insiders Are Buying
Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked.
Merit Medical Systems, Inc. (MMSI): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the 21st century investor’s toolkit, there are a multitude of methods shareholders can use to track Mr. Market.
Antares Pharma Inc (ATRS): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the eyes of most shareholders, hedge funds are perceived as worthless, old financial vehicles of the past.
Here is What Hedge Funds Think About AngioDynamics, Inc. (ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO) was in 11 hedge funds' portfolio at the end of the first quarter of 2013.
Merit Medical Systems, Inc. (MMSI): Hedge Funds and Insiders Are Bearish, What Should You Do?
Merit Medical Systems, Inc. (NASDAQ:MMSI) was in 11 hedge funds' portfolio at the end of the first quarter of 2013.
Should You Avoid OraSure Technologies, Inc. (OSUR)?
In today’s marketplace, there are dozens of gauges shareholders can use to monitor their holdings. A pair of the best are hedge fund and insider trading activity.
AngioDynamics, Inc. (ANGO): Are Hedge Funds Right About This Stock?
In the eyes of most stock holders, hedge funds are seen as worthless, outdated investment tools of the past.
AngioDynamics, Inc. (ANGO), ADTRAN, Inc. (ADTN) & More: Five Reasons to Worry About Next Week
Stocks suffered their largest daily drop in more than a month on Wednesday after an unsettling snapshot of corporate America.
3 Horrendous Health-Care Stocks This Week: Impax Laboratories Inc (IPXL), Depomed Inc (DEPO), AngioDynamics, Inc. (ANGO)
Mr. Market was a happy camper this week, with the Dow setting all-time highs. However, a few stocks in the health-care sector didn't join the party.
